Clinical Trials Browser

Interventional × Klatskin Tumor × toripalimab × Clear all

NCT06717464 2024-12-05

Toripalimab Combined With Capecitabine as Postoperative Adjuvant Therapy for Patients With Resectable Advanced Extrahepatic Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Gallbladder Neoplasms, Klatskin Tumor

NCT04211168 2023-03-29

Toripalimab Plus Lenvatinib as Second-line Treatment in Advanced Biliary Tract Cancers

Phase 2 Unknown

Gastrointestinal

Gallbladder Neoplasms, Cholangiocarcinoma, Klatskin Tumor